Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.

about

Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions

P2860

Q47941425-CE80A8B3-154B-4366-89AF-DA14B48ECC5E Q58122023-17A763B7-8BF4-4D3F-85E5-6E0D41AD3411

P2860

Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.

Item

http://www.wikidata.org/entity/Q41591129

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Efficacy of statins on sirtuin ...... uman coronary atherosclerosis.

@en

type

Item

label

Efficacy of statins on sirtuin ...... uman coronary atherosclerosis.

@en

prefLabel

Efficacy of statins on sirtuin ...... uman coronary atherosclerosis.

@en

P1476

Efficacy of statins on sirtuin ...... uman coronary atherosclerosis.

@en

P2093

Ahmet Bacaksiz

http://www.w3.org/2001/XMLSchema#string

Birsen Elibol-Can

http://www.w3.org/2001/XMLSchema#string

Omer Uysal

http://www.w3.org/2001/XMLSchema#string

Ozlem Gok

http://www.w3.org/2001/XMLSchema#string

Ulkan Kilic

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

Sirt1 modulates premature senescence-like phenotype in human endothelial cells

Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.

Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.

Explaining inter-individual variability in phenotype: is epigenetics up to the challenge?

P304

321-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1440-1681.12362

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25582759

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.

about

P2860

P2860

Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921